McGuireWL. Breast cancer prognostic factors: evaluation guidelines. J Natl Cancer Inst1991;83:154-5.
2.
Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy, 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet1992;339:1-15, 71-85.
3.
DeschCE, HillnerBE, SmithTJ, RetchinSM. Should the elderly receive chemotherapy for node-negative breast cancer? A cost effectiveness analysis examining total and active life-expectancy outcomes. J Clin Oncol1993;11:777-82.
4.
Nolvadex Adjuvant Trial Organization. Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at eight years by Nolvadex Adjuvant Trial Organization. Br J Cancer1988;57:608-11.
